Middle East, North Africa, Afghanistan & Pakistan vs Russia: Immunization, HepB3
Middle East, North Africa, Afghanistan & Pakistan
84.4%
in 2024
Russia
97.0%
in 2024
Middle East, North Africa, Afghanistan & Pakistan rank
24th
Russia rank
26th
Immunization, HepB3 over time
- Middle East, North Africa, Afghanistan & Pakistan
- Russia
How they compare
Russia currently reports 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan, a difference of 12.6%.
That makes Russia's figure about 1.1 times Middle East, North Africa, Afghanistan & Pakistan's.
Across all 24 years both countries report, Russia has been ahead every year.
Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Russia ranks 26th of 47 groups.
Russia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Middle East, North Africa, Afghanistan & Pakistan | Russia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 66.0% | 89.2% | 23.2% | Russia |
| 2010s | 80.5% | 97.0% | 16.5% | Russia |
| 2020s | 83.4% | 97.0% | 13.6% | Russia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hepb3, Middle East, North Africa, Afghanistan & Pakistan or Russia?
- Russia, at 97.0% against 84.4% in Middle East, North Africa, Afghanistan & Pakistan as of 2024.
- What is the difference in immunization, hepb3 between Middle East, North Africa, Afghanistan & Pakistan and Russia?
- 12.6%, with Russia ahead.
- How many years of comparable data are there for Middle East, North Africa, Afghanistan & Pakistan and Russia?
- 24 years are reported by both, from 2001 to 2024.
- How do Middle East, North Africa, Afghanistan & Pakistan and Russia rank globally for immunization, hepb3?
- Middle East, North Africa, Afghanistan & Pakistan ranks 24th and Russia ranks 26th of 47 groups.
- Where does this data come from?
- World Health Organization (WHO), published as Immunization, HepB3 (% of one-year-old children). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.